Daniel Teper

CEO at IMMUNE Pharmaceuticals

New York, NY, US


Dr. Daniel Teper is the founder and CEO of IMMUNE Pharmaceuticals.Dr Teper was previously a New York based Partner at leading Strategy Consulting firms advising Pharma and Public Biotech companies. He has also held senior executive positions in the US and Europe at Novartis, GSK and Sanofi-Aventis, and is a co-founder of Novagali (NYSE Euronext: NOVA), which was recently acquired by Japan's Santen. Dr. Teper holds a Doctor of Pharmacy degree from Paris XI University and an MBA from INSEAD.

Speaking Sessions/Events


Can Israel Become the Next Biotech Start-Up Nation?

9:00 AM–9:45 AM on Tuesday, Apr 23, 2013